MedPath

Better Sleep in Psychiatric Care - ADHD Pilot Study

Not Applicable
Completed
Conditions
Sleep Wake Disorders
Attention Deficit Disorder
Sleep Initiation and Maintenance Disorders
Interventions
Behavioral: CBT-i/ADHD
Registration Number
NCT03852966
Lead Sponsor
Karolinska Institutet
Brief Summary

Comorbidities, including sleep problems, are common in adult Attention Deficit Hyperactivity Disorder (ADHD). Treatment of choice for insomnia is cognitive behavioral therapy (CBT-i), but evidence is lacking for CBT-i in patients with ADHD and sleep problems.

The purpose of this study was to investigate if patients at a specialist clinic for ADHD benefit from a group delivered CBT-i treatment; whether insomnia severity improves following this treatment.

This pragmatic within-group pilot study with a pre to post and three-month follow-up design was set at a specialist psychiatric out-patient clinic for adult ADHD.

As an adjunct to care-as-usual at the clinic, a CBT-i-based group treatment targeting sleep problems prevalent in the ADHD-population, designed for patients with executive difficulties, was offered as 10 weekly 90-minute group sessions and scheduled telephone support.

All outcome measures were subjectively reported by participants. Data analyzed with dependent t-tests according to intent-to-treat.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • being a patient at the clinic (i.e. having a diagnosis of AD(H)D)
  • self-reported sleep problems
  • returning pre-treatment questionnaires and signed consent form
Read More
Exclusion Criteria
  • none
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CBT-i/ADHDCBT-i/ADHDBehavioral treatment for sleep problems in ADHD
Primary Outcome Measures
NameTimeMethod
Insomnia Severity Index (ISI)Change from baseline to 24 weeks

7-item self-reported measure of insomnia severity, 0-28 Points. Higher values represents higher severity (worse outcome)

Secondary Outcome Measures
NameTimeMethod
Adult ADHD Self-Report Scale (ASRS)Change from baseline to 24 weeks

18-item self-reported measure of inattention and hyperactivity symptoms. Total score 0-72. Subscale inattention/hyperactivity 0-36 points per scale. Higher scores represents more severe symptoms (worse outcome).

Trial Locations

Locations (1)

Department of ADHD, Northern Stockholm Psychiatry

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath